Back to results
US 2015/0031738 A1Published application
Cyclic compounds and methods of making and using the same
AssigneeUniversity of Massachusetts
InventorsYan Li, Hitest Thaker, Gregory N. Tew, Dahui Liu, Wenxi Pan
Life of this patent
Estimating the term…
Abstract
The present invention provides compounds, or pharmaceutically acceptable salts thereof, for inhibiting the growth of a microbe; treating a mammal having a microbial infection, mucositis, an ophthalmic infection, an otic infection, a cancer, or a Mycobacterium infection; inhibiting the growth of a Mycobacterium species; modulating an immune response in a mammal; or antagonizing unfractionated heparin, low molecular weight heparin, or a heparin/low molecular weight heparin derivative.
Claims13
A compound of Formula II
- wherein:
- X is
- R1 is H,
- R2 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R3 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R4 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R5 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R6 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- and
- R7 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- or a pharmaceutically acceptable salt thereof;
- or
- a compound of Formula I
- wherein:
- X is
- R1 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R2 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R3 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R4 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R5 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R6 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- and
- R7 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- or a pharmaceutically acceptable salt thereof;
- or
- a compound of Formula III
- wherein:
- X is
- R1 is H,
- R2 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R3 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R4 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R5 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R6 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- and
- R7 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- or a pharmaceutically acceptable salt thereof;
- or
- a compound of Formula IV
- wherein:
- R1 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R2 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R3 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R4 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R5 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- R6 is H, —NH(CH2)nNH2, —NH(CH2)nNC(═N)NH2, —(CH2)nNH2, —O—(CH2)nNH2, —(CH2)nNC(═N)NH2, —O—(CH2)nNC(═N)NH2, —CH═CH—CH2NH2, —CH═CH—CH2NC(═N)NH2, —CH═CH—(CH2)2NH2, —CH═CH—(CH2)2NC(═N)NH2, —C≡C—CH2NH2, —C≡C—(CH2)2NH2, —CH≡CH—CH2NC(═N)NH2, or —C≡C—(CH2)2—NC(═N)NH2, where n is 2, 3, or 4;
- and
- or a pharmaceutically acceptable salt thereof;
- or
- a compound of Formula V:
- R1-A1-X—Z—X-A1-R2 (V)
- or a pharmaceutically acceptable salt thereof,
- wherein:
- each X is, independently, —NR8, —N(R8)N(R8)—, O, or S, wherein each R8 is, independently, hydrogen or alkyl;
- each Z is, independently, C═O, C═S, or O═S═O;
- each A1 is, independently, aryl optionally substituted with one or more W, or heteroaryl optionally substituted with one or more W;
- each W is, independently, —CF3, halo, C1-4alkyl, —O—(CH2)1-5NHC(═NH)NH2, —N((CH2)1-5—NH2)((CH2)1-5N(C1-4alkyl)2), —N((CH2)1-5N(C1-4alkyl)2)2, heterocycle, —S—(CH2)1-5NHC(═NH)NH2, —S—(CH2)1-5NH2, —S—(CH2)1-5N(CH3)2, —C1-4alkyl, —S—(CH2)1-5NHS(═O)2—C1-4alkyl, O-heterocycle (wherein the heterocycle is optionally substituted with one or more cyano, amino, C1-4alkyl, C1-4alkoxy, guanidino, hydroxyl, amidino, or halo);
- and
- R1 and R2 are, independently, hydrogen, halo, —NO2, —S—(CH2)1-5NHC(═NH)NH2, —O—(CH2)1-5NHC(═NH)NH2, —CF3, —N+(═O)O−, —(CH2)1-5NHC(═NH)NH2, amino, —S—(CH2)1-5N(CH3)2, —O—(CH2)1-5N(CH3)2, —O-heterocycle (wherein the heterocycle is optionally substituted), —S-heterocycle (wherein the heterocycle is optionally substituted), —NHC(═O)—C1-4alkyl, —NHC(═O)—(CH2)1-5NHC(═NH)NH2, —NHC(═O)—(CH2)1-5-aryl (wherein either or both the —(CH2)1-5 or phenyl is optionally substituted), —NHC(═O)—(CH2)1-5NH-aryl (wherein either or both —NH and/or aryl is optionally substituted), —NHC(═O)-aryl (wherein the aryl is optionally substituted), or —NHC(═O)—(CH2)1-5NHS(═O)2—C1-4alkyl, wherein the optional substituents are chosen from one or more cyano, amino, C1-4alkyl, guanidino, hydroxyl, amidino, C1-4alkoxy, CF3, and halo.
56 more elements
2-11. (canceled)
13-88. (canceled)
97-140. (canceled)
Dependencies are inferred from the claim text.